6181 - 6190 of 6255 Results
Title
Year
- Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s disease2023OPENTitle: Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 40Issue #:Start Page: 103523End Page: 103523Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103523Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103523Citation Count: 14
- Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study2023OPENTitle: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29375Citation Count: 19
-
OPENTitle: A History of Senile Plaques: From Alzheimer to Amyloid ImagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 6Start Page: 387End Page: 413Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac030Best OA location URL: https://academic.oup.com/jnen/article-pdf/81/6/387/43778548/nlac030.pdfCitation Count: 26
- Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage2015OPENTitle: Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damageJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 2Start Page: 347End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13242Citation Count: 60
- ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling2022OPENTitle: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signalingJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202106046Best OA location URL: https://rupress.org/jcb/article-pdf/221/7/e202106046/1434249/jcb_202106046.pdfCitation Count: 75
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22
- Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders2016OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564Citation Count: 15
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations2024OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://doi.org/10.1002/mds.29902Citation Count: 16
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6333467Citation Count: 167
- Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors2023OPENTitle: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase InhibitorsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 18Issue #: 4Start Page: 810End Page: 821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.2c00868Best OA location URL: https://escholarship.org/content/qt9kp29910/qt9kp29910.pdfCitation Count: 13